Sonepcizumab
Product Specifications
CAS Number
1031360-18-5
Target
LPL Receptor
Related Pathways
GPCR/G Protein
Purity
0.989
Bioactivity
Sonepcizumab (LT 1009) is a fully humanized monoclonal antibody against S1P, with anti-cancer activity, useful for studying metastatic renal cell carcinoma (mRCC) and preventing eye scarring after glaucoma filtration surgery.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS2150593-01 0.1 mL
APC_Cy7-Linked Monoclonal Antibody to Transforming Growth Factor Beta 1 (TGFb1)
Ask
View Details 
MBS2150593-02 0.2 mL
APC_Cy7-Linked Monoclonal Antibody to Transforming Growth Factor Beta 1 (TGFb1)
Ask
View Details MBS2150593-03 0.5 mL
APC_Cy7-Linked Monoclonal Antibody to Transforming Growth Factor Beta 1 (TGFb1)
Ask
View Details MBS2150593-04 1 mL
APC_Cy7-Linked Monoclonal Antibody to Transforming Growth Factor Beta 1 (TGFb1)
Ask
View Details 
MBS2150593-05 5 mL
APC_Cy7-Linked Monoclonal Antibody to Transforming Growth Factor Beta 1 (TGFb1)
Ask
View Details MBS2150593-06 5x 5 mL
APC_Cy7-Linked Monoclonal Antibody to Transforming Growth Factor Beta 1 (TGFb1)
Ask
View Details